Browse Category

Stock Market News 9 October 2025

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Sources: Akero Therapeutics investor materials; Novo Nordisk press statements; Reuters, TS2.tech and FierceBiotechnews reports ts2.tech ts2.tech Fiercebiotech; MarketBeat and DirectorsTalk analyst surveys Marketbeat Directorstalkinterviews; Economic Times deal summary Indiatimes Indiatimes; Business Wire legal alert Businesswire Businesswire; and TradingView market data Marketbeat Tradingview.
Go toTop